CASBF
Price
$3.37
Change
+$0.07 (+2.12%)
Updated
Jan 16 closing price
Capitalization
1.92B
CHSYF
Price
$0.93
Change
-$0.00 (-0.00%)
Updated
May 1 closing price
Capitalization
4.12B
Ad is loading...

CASBF vs CHSYF

Header iconCASBF vs CHSYF Comparison
Open Charts CASBF vs CHSYFBanner chart's image
CANSINO BIOLOGICS
Price$3.37
Change+$0.07 (+2.12%)
Volume$765
Capitalization1.92B
China Medical System Holdings
Price$0.93
Change-$0.00 (-0.00%)
Volume$110
Capitalization4.12B
CASBF vs CHSYF Comparison Chart
Loading...
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CASBF vs. CHSYF commentary
Jan 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CASBF is a Hold and CHSYF is a Hold.

Ad is loading...
COMPARISON
Comparison
Jan 20, 2025
Stock price -- (CASBF: $3.37 vs. CHSYF: $0.93)
Brand notoriety: CASBF and CHSYF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: CASBF: 88% vs. CHSYF: 100%
Market capitalization -- CASBF: $1.92B vs. CHSYF: $4.12B
CASBF [@Pharmaceuticals: Other] is valued at $1.92B. CHSYF’s [@Pharmaceuticals: Other] market capitalization is $4.12B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.56B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CASBF’s FA Score shows that 1 FA rating(s) are green whileCHSYF’s FA Score has 2 green FA rating(s).

  • CASBF’s FA Score: 1 green, 4 red.
  • CHSYF’s FA Score: 2 green, 3 red.
According to our system of comparison, CHSYF is a better buy in the long-term than CASBF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CASBF’s TA Score shows that 3 TA indicator(s) are bullish.

  • CASBF’s TA Score: 3 bullish, 5 bearish.

Price Growth

CASBF (@Pharmaceuticals: Other) experienced а -4.96% price change this week, while CHSYF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +0.30%. For the same industry, the average monthly price growth was +2.86%, and the average quarterly price growth was -9.85%.

Industries' Descriptions

@Pharmaceuticals: Other (+0.30% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CHSYF($4.12B) has a higher market cap than CASBF($1.92B). CASBF has higher P/E ratio than CHSYF: CASBF (9.30) vs CHSYF (8.13). CHSYF YTD gains are higher at: 0.000 vs. CASBF (-15.671). CHSYF has higher annual earnings (EBITDA): 3.74B vs. CASBF (1.09B). CASBF has more cash in the bank: 7.01B vs. CHSYF (5.25B). CHSYF has less debt than CASBF: CHSYF (1.8B) vs CASBF (2.14B). CHSYF has higher revenues than CASBF: CHSYF (8.94B) vs CASBF (2.87B).
CASBFCHSYFCASBF / CHSYF
Capitalization1.92B4.12B47%
EBITDA1.09B3.74B29%
Gain YTD-15.6710.000-
P/E Ratio9.308.13114%
Revenue2.87B8.94B32%
Total Cash7.01B5.25B133%
Total Debt2.14B1.8B118%
FUNDAMENTALS RATINGS
CHSYF: Fundamental Ratings
CHSYF
OUTLOOK RATING
1..100
50
VALUATION
overvalued / fair valued / undervalued
1..100
1
Undervalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
33
PRICE GROWTH RATING
1..100
73
P/E GROWTH RATING
1..100
77
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CASBFCHSYF
RSI
ODDS (%)
Bullish Trend 12 days ago
76%
N/A
Stochastic
ODDS (%)
Bullish Trend 12 days ago
56%
N/A
Momentum
ODDS (%)
Bearish Trend 12 days ago
78%
N/A
MACD
ODDS (%)
Bearish Trend 12 days ago
82%
N/A
TrendWeek
ODDS (%)
Bearish Trend 12 days ago
76%
Bullish Trend 12 days ago
7%
TrendMonth
ODDS (%)
Bearish Trend 12 days ago
71%
Bullish Trend 12 days ago
7%
Advances
ODDS (%)
N/A
N/A
Declines
ODDS (%)
Bearish Trend 12 days ago
80%
N/A
BollingerBands
ODDS (%)
Bullish Trend 12 days ago
56%
N/A
Aroon
ODDS (%)
N/A
N/A
View a ticker or compare two or three
Ad is loading...
CASBF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
PGWCX32.810.40
+1.23%
Virtus Silvant Focused Growth C
AOTIX28.530.25
+0.88%
Virtus EM Opps Instl
FSKGX18.970.16
+0.85%
Fidelity Growth Strategies K6
MKVFX13.250.08
+0.61%
MFS International Large Cap Value R3
BKLSX9.670.05
+0.52%
BlackRock U.S. Insights Long/Shrt Eq K

CASBF and

Correlation & Price change

A.I.dvisor tells us that CASBF and CRLBF have been poorly correlated (+3% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CASBF and CRLBF's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CASBF
1D Price
Change %
CASBF100%
N/A
CRLBF - CASBF
3%
Poorly correlated
+0.63%
CNTMF - CASBF
2%
Poorly correlated
-2.22%
BUDZ - CASBF
2%
Poorly correlated
-6.25%
CBWTF - CASBF
1%
Poorly correlated
-3.32%
CPHRF - CASBF
0%
Poorly correlated
+3.96%
More

CHSYF and

Correlation & Price change

A.I.dvisor tells us that CHSYF and BSPK have been poorly correlated (+9% of the time) for the last year. This A.I.-generated data suggests there is low statistical probability that CHSYF and BSPK's prices will move in lockstep.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CHSYF
1D Price
Change %
CHSYF100%
N/A
BSPK - CHSYF
9%
Poorly correlated
+23.82%
CANN - CHSYF
7%
Poorly correlated
+2.35%
CNPOF - CHSYF
5%
Poorly correlated
N/A
CAIHF - CHSYF
0%
Poorly correlated
N/A
CASBF - CHSYF
0%
Poorly correlated
N/A
More